Core Insights - ETHZilla's shares fell nearly 5% following the announcement of a 1-for-10 reverse stock split, effective October 20 [1] - The reverse split aims to enhance engagement with institutional investors by increasing stock prices above $10.00, aligning with institutional standards [2] - The outstanding share count will decrease from approximately 160 million to around 16 million as a result of the split [2] Company Strategy - ETHZilla, previously known as 180 Life Sciences, rebranded in late July to focus on becoming one of the largest Ethereum holders, initially raising $425 million through a PIPE offering [3] - Following the strategy announcement, shares surged when Peter Thiel and related entities acquired a 7.5% equity stake, but subsequently fell sharply, prompting a $250 million share buyback [4] - Despite fluctuations, shares have increased over 105% in the last six months, although they closed at $1.83 after the recent drop [4] Financial Position - Currently, ETHZilla holds 102,246 ETH, valuing its treasury at approximately $407 million based on current ETH prices, making it the sixth-largest publicly traded Ethereum treasury [5] - The stock split will not affect ETHZilla's plans for ETH accumulation, which is only one aspect of its business model [5] Future Initiatives - The company is working on various initiatives, including tokenization solutions, DeFi protocol integration, blockchain analytics, and traditional-to-digital asset conversion gateways [6] - Updates on these initiatives are expected in the coming weeks and months [6]
ETHZilla Stock Falls After Ethereum Treasury Firm Reveals 1-for-10 Reverse Stock Split
Yahoo Finance·2025-10-15 20:15